Press Releases | Archives

April 1, 2020

NEW MANAGEMENT TEAM

Canon Medical Systems Europe names Mr. Nobuyuki Hatakeyama President and Chief Executive Officer – Mr. Rene Degros and Mr. Rob de Jong join the European management team – Zoetermeer, the Netherlands.

March 26, 2020

Rapid Genetic Testing System for the Novel Coronavirus (SARS-CoV-2) Jointly Developed by Canon Medical Systems Corporation and Nagasaki University Now Available for Practical Application in Government-Conducted Testing

Canon Medical Systems Corporation, working together with Nagasaki University, has completed development of Genelyzer KIT, a set of reagents for SARS-CoV-2 RNA testing based on a gene amplification technique known as the fluorescent LAMP method.

March 23, 2020

PRESIDENT MESSAGE COVID19

18 March 2020 Dear valued customer I would like to take this opportunity to share with you some important information regarding Canon Medical’s response to the COVID-19 virus.

March 19, 2020

Development of a Rapid Genetic Testing System for the Novel Coronavirus and Start of Research into Its Practical Application

Canon Medical Systems Corporation has begun research into the practical application of a new rapid genetic testing system for the novel coronavirus (SARS-CoV-2) which is being developed by Canon Medical Systems Corporation in cooperation with Nagasaki University.

February 27, 2020

CANON MEDICAL TO COMMENCE DEVELOPMENT OF A RAPIDGENETIC TESTING SYSTEM FOR THE NOVEL CORONAVIRUS (COVID-19)

Ohtawara, Japan; February 26 – Canon Medical Systems Corporation (Canon Medical) announces the start of development of a rapid genetic testing system for the novel coronavirus (COVID-19) reaffirming the company’s commitment to the basic research and development of rapid diagnostic test kits.

Contact Us